Hide Board Information

Show Board Information

Cap Gemini Sa Adr CGEMY

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/26/2019 3:35:40 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Cap Gemini Sa Adr (OTCMRKTS: CGEMY) Stock Message Board

1. CGEMY Company Profile

    

2. CGEMY Time & Sales

    

3. CGEMY Recent News

    

4. CGEMY Filings

    

5. CGEMY Financials

    

6. CGEMY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	$CGEMY News Article - Capgemini extends its	whytestocks	11/26/2019 3:35:40 PM
5	$CGEMY News Article - Capgemini appoints Elfije	whytestocks	11/21/2019 3:10:42 PM
4	Latest Cap Gemini Sa ADR (CGEMY) Headlines	Stock_Tracker	03/09/2014 7:19:44 AM
3	CGEMY 38.62 Stock Charts $CGEMY 1 Month Chart	chartguy89	03/06/2014 9:38:10 AM
2	CGEMY Recent News Rollins Expands Global	Stock_Tracker	03/03/2014 6:20:34 PM
1	CGEMY Stock Charts Monday, February 24, 2014 at	chartguy89	02/24/2014 10:15:08 AM

Recent Articles

• Sandoz Explores Acquisition of Just-Evotec Biologics
• Fiverr International Ltd Reports Impressive Q2 2025 Earnings
• Photocure ASA Reports Impressive Growth in Q2 2025 Results
• Photocure ASA Sees Growth in Hexvix/Cysview Revenue Performance
• Nexans Begins Search for New CFO Amid Leadership Changes
• Sanofi's Revolutionary Approach in Treating Multiple Myeloma
• Worldline Unveils Dynamic Management Team for Future Growth
• Fiverr Q2 2025 Report Highlights Growth Amid AI Expansion
• Vopak's Remarkable First Half 2025 Performance Boosts Outlook
• Sandoz Moves Forward with Acquisition of Just-Evotec Biologics
• IMCD Achieves Maiden Financial Success with 275 Million EBITA
• Photocure ASA Reports Impressive Q2 Growth and Outlook
• Ascom Partners with SEC-COM to Enhance German Healthcare Solutions
• Nexans Exceeds Expectations as 2025 Guidance is Enhanced
• Capgemini Reports Mixed H1 2025 Results Amid Global Challenges
• Worldline's H1 2025 Results: A Comprehensive Overview
• JDE Peet's Shows Robust Growth in First Half Financial Season
• JDE Peet’s Reports Strong Half-Year Financial Results
• Idorsia's Financial Strength Shines as QUVIVIQ Sales Surge
• Solvay's Financial Review: Navigating Challenges in 2025
• Melexis Reports Impressive Q2 2025 Financial Performance
• Sanofi’s Breakthrough Antibody Awarded Orphan Drug Status for Myeloma
• Nexans Begins Search for New Chief Financial Officer Amid Changes
• Vopak Sees Growth in HY1 2025, Upgrades Full-Year Projections
• Worldline's Financial Performance Insights for H1 2025
• Capgemini's Mid-Year 2025 Results Showcase Growth Amid Challenges
• Worldline's Revamped Leadership Team Driving Strategic Change
• IMCD N.V. Achieves Impressive EBITA Growth in 2025
• Innovations in Furniture Design Set for Shanghai in 2025
• NOR Flash Market Set for Growth: Insights & Forecast to 2034
• Analyzing the Impact of Trump's EU Trade Agreement
• Furniture China 2025: Innovations and Trends in Design
• Hepsor AS Reports Significant Revenue Growth in Q2 2025
• Hepsor AS Reports Strong Revenue Growth in Q2 Performance
• Analysis of Trends in Securities Class Actions for 2025
• Transforming U.S. Textile Waste into Opportunities Abroad
• Larimar Therapeutics Sets Public Offering Pricing at $3.20/share
• Tigo Energy's Remarkable Stock Surge Post Q2 Financial Releases
• Revolutionizing E-Commerce: BROTHER's 30% Sales Surge
• Emergency Tsunami Alerts Issued as Earthquake Shakes Pacific
• Innovative AI Strategies from Alphabet Inc. for Future Growth
• China Southern Power Grid's Innovative AI Showcase at WAIC
• Investors Alert: Join the Hims & Hers Health Class Action
• Building Bridges: A Cultural Exchange Through Nature
• Nokia Enhances Surge's Subsea Network for Broader Access
• Xanadu Mines Advances with Strategic Moves for Kharmagtai
• Major Legal Developments for Tempus AI Shareholders Awaiting Justice
• Understanding the Reckitt Benckiser Class Action Lawsuit Alert
• Class Action Insight: Flywire Shareholders urged to Act Now
• UnitedHealth Group's Bold Moves Amidst Medical Cost Crisis